Moderna COVID-19 vaccine
RNA COVID-19 vaccine
Moderna COVID-19 vaccine ▸ Facts ▸ Comments ▸ News ▸ Videos
The Moderna COVID‑19 vaccine, sold under the brand name Spikevax, is a COVID-19 vaccine developed by American company Moderna, the United States National Institute of Allergy and Infectious Diseases (NIAID), and the Biomedical Advanced Research and Development Authority (BARDA). Depending on the jurisdiction, it is authorized for use in people aged six months, twelve years, or eighteen years and older. It provides protection against COVID-19 which is caused by infection by the SARS-CoV-2 virus. It is designed to be administered as two or three 0.5 mL doses given by intramuscular injection at an interval of at least 28 days apart.
| 1 shares | ShareTweetSavePostSend |
You Might Like
Moderna sues Pfizer/BioNTech over COVID vaccine Moderna is suing Pfizer and its German partner BioNTech for alleged patent infringement in the development of the first COVID-19 vaccine approved in the US.Sky News - Published | |
Indian Covid vaccines better than Pfizer, Moderna: Adar PoonawallaSerum Institute of India CEO Adar Poonawalla on Wednesday claimed that "Made in India" Covid vaccines have provided more protection against the coronavirus infection than mRNA vaccines like Pfizer and..IndiaTimes - Published | |
Pfizer and Moderna jabs give best overall boost, UK study finds The Pfizer and Moderna vaccines being used in the UK as boosters prompt the best overall response, according to a UK trial.Sky News - Published | |
Omicron variant 'highly infectious' and COVID booster jabs may need 'double' dose, says Moderna CEO The head of drugmaker Moderna said he believes the Omicron variant is "highly infectious" and it is "highly possible" the effectiveness of vaccines is decreasing - adding that boosters may need a..Sky News - Published | |
New variant may force drug companies to tweak Covid vaccination plansThe emergence of the Omicron strain could lead drug companies scrambling to the drawing board to tweak their Covid-19 vaccine plans. US firm Novavax and Russia’s Gamaleya Institute said on Monday..IndiaTimes - Published | |
With domestic manufacturing picking up pace, India unlikely to buy Pfizer, Moderna vaccines for now: SourcesIndiaTimes - Published | |
UK regulator approves Moderna COVID-19 vaccine for 12 to 17-year-oldsThe UK health regulator has approved the Moderna coronavirus vaccine for 12 to 17-year-olds.Sky News - Published | |
Moderna and Pfizer jabs linked to mild heart inflammation but 'benefits still outweigh risks' The Pfizer/BioNTech and Moderna jabs have been linked to cases of mild heart inflammation - but the benefits still outweigh the risks, according to European and UK health agencies.Sky News - Published | |
India expects 3-4 million Pfizer, Moderna vaccine doses through Covax by August- sourcesIndia expects to receive 3 million to 4 million doses of the Pfizer and Moderna Covid-19 shots through the Covax facility by August, two sources said, as it tries to expand inoculations to prevent..IndiaTimes - Published | |
Indemnity issue holds up J&J, Pfizer and Moderna jabsIndiaTimes - Published | |
DCGI gives emergency use nod to Moderna’s vaccineIndian pharma major Cipla will “facilitate” the import of Covid vaccines donated by US biotech major Moderna, possibly in the near future, under licence for restricted use by India’s drug..IndiaTimes - Published | |
Covid-19: Govt's five-fold strategy of management; Moderna gets nod as 4th vaccine in India, and moreIndiaTimes - Published | |
India expands vaccine kitty: Moderna gets regulatory nod; Pfizer approval likely soonIndia on Tuesday cleared the decks for the import of Moderna's Covid vaccine, adding another option to its list of anti-Covid shots. Moderna's vaccine, developed in the United States, will be the..IndiaTimes - Published | Moderna seeks regulatory approval for its Covid-19 vaccine in IndiaIndiaTimes - Published |
Good news! Pfizer gears up to supply 1 billion vaccine doses to India in 2021, approval in "final stages"The Indian government may be set to grant indemnity from liability to Pfizer and Moderna in a bid to fast-track their vaccine's approval.DNA - Published | Moderna offers to sell booster shots from January; indemnity-waiver talks onUS vaccine maker Moderna has offered to sell booster doses of its Covid vaccine to India, from January 2022 even as the government continues to hold negotiations with Moderna and J&J on the indemnity..IndiaTimes - Published |
India in talks with Pfizer, J&J, Moderna for local manufacturing of COVID vaccines: Harsh Vardhan ShringlaLast month saw India getting the first batches of Suptink V vaccines, which will be also produced by Indian companies.DNA - Published | After Pfizer, Serum Institute seeks indemnity over Covid-19 vaccine: SourcesAmid discussions over possible legal protection to foreign vaccine manufacturers Pfizer and Moderna over their Covid-19 jabs in India, the Serum Institute of India (SII) has also sought protection..IndiaTimes - Published |
DCGI waiver likely to bring foreign vaccines like Pfizer, Moderna a step closer​In a letter, DCGI Chief VG Somani letter said that this will be applicable for vaccines that have already been approved for restricted use by the US FDA, EMA, UK MHRA, PMDA Japan or listed for..IndiaTimes - Published | COVID-19: Big relief for foreign vaccine makers as DCGI exempts post-approval bridging trialsCipla, which has been looking to commit USD 1 billion into bringing Moderna's single-dose mRNA booster vaccine to India, also requested an exemption.DNA - Published |
Government in talks to boost vaccine arsenalThe government is in talks with global vaccine giants Moderna and Pfizer to source Covid-19 shots on an immediate basis, to increase supply in the next two-three months itself. While the Centre expects..IndiaTimes - Published | Moderna's single-dose Covid-19 vaccine in India likely next year; Pfizer ready with 5 crore doses for 2021Moderna is expecting to launch a single-dose Covid-19 vaccine in India next year and is in talks with Cipla among other Indian firms, while another US giant Pfizer is ready to offer 5 crore shots in..IndiaTimes - Published |
Moderna refuses to send vaccine doses directly to Punjab government, here's whyDivulging further, the State Nodal Officer said that reply was received from Moderna only in which the company refused to deal with State Government.DNA - Published Also reported by •IndiaTimes | Will deal only with Centre: Pfizer, ModernaMassachusetts-based biotechnology company Moderna, which has developed a messenger RNA (mRNA) vaccine to tackle Covid-19, has declined the Punjab government’s request for direct supply of its vaccine..IndiaTimes - Published |
